MedTrace Logo

Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDP

NCT03779828 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2021-01-15

No results posted yet for this study

Summary

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic demyelinating polyneuropathy of autoimmune origin with a progressive or relapsing course.

Diagnosis is based on clinical presentation and electrophysiological findings in accordance with the EFNS/PNS consensus guidelines. IVIg is the first line treatment witch has been shown to be effective in several placebo-controlled trials.

Once IVIg therapy produces a response and is well tolerated, some patients are able to continue their treatment in the home setting. The HOME LINK system offers an integrated, global solution based on telemonitoring technology providing continuous, remote monitoring of Privigen® infusions administered at home.

Conditions

Interventions

DEVICE

HOME LINK

Telemonitoring system which include web platform and connected devices.

Sponsors & Collaborators

  • CSL Behring

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-27
Primary Completion
2019-06-03
Completion
2019-06-03

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03779828 on ClinicalTrials.gov